APA (7th ed.) Citation

YH, L., HF, J., & YT, H. (2025). Development of a decellularized liver matrix-based nanomedicine for metabolic dysfunction-associated steatotic liver disease. Biomaterials science, 13(22), 6350. https://doi.org/10.1039/d5bm01241d

Chicago Style (17th ed.) Citation

YH, Lin, Jheng HF, and Hou YT. "Development of a Decellularized Liver Matrix-based Nanomedicine for Metabolic Dysfunction-associated Steatotic Liver Disease." Biomaterials Science 13, no. 22 (2025): 6350. https://doi.org/10.1039/d5bm01241d.

MLA (9th ed.) Citation

YH, Lin, et al. "Development of a Decellularized Liver Matrix-based Nanomedicine for Metabolic Dysfunction-associated Steatotic Liver Disease." Biomaterials Science, vol. 13, no. 22, 2025, p. 6350, https://doi.org/10.1039/d5bm01241d.